House Ways and Means Subcommittee on Health

House Ways and Means Subcommittee on Health
Name	House Ways and Means Subcommittee on Health
Chamber	United States House of Representatives
Parent committee	United States House Committee on Ways and Means
Jurisdiction	Health policy, entitlement programs
Established	20th century
Chair	varies by Congress
Ranking member	varies by Congress

Contents

House Ways and Means Subcommittee on Health The House Ways and Means Subcommittee on Health is a standing subcommittee of the United States House Committee on Ways and Means with primary responsibility for federal health programs, entitlements, and related taxation matters. Established within the legislative structure that includes the United States House Committee on Rules and the United States House Committee on Energy and Commerce, the subcommittee interacts with major legislative actors such as members from the United States Senate Committee on Finance, administrators from the Centers for Medicare & Medicaid Services, and officials from the Department of Health and Human Services.

History

The subcommittee traces roots to early 20th‑century congressional deliberations on social insurance influenced by events like the Great Depression, the enactment of the Social Security Act, and later expansions under the Medicare Modernization Act. Its formation and evolution involved cross-branch interactions with the White House administrations of presidents including Franklin D. Roosevelt, Lyndon B. Johnson, and Barack Obama during major health policy milestones such as the creation of Medicare and the passage of the Patient Protection and Affordable Care Act. Over successive Congresses the subcommittee’s scope shifted in response to fiscal debates in episodes like the Budget Control Act of 2011 and litigation such as cases argued before the Supreme Court of the United States concerning healthcare statutes.

The subcommittee’s jurisdiction encompasses federal entitlement programs administered by agencies including the Centers for Medicare & Medicaid Services and interactions with statutes like the Social Security Act, the Medicare Access and CHIP Reauthorization Act of 2015, and provisions of the Patient Protection and Affordable Care Act. Responsibilities include drafting tax provisions affecting health coverage tied to the Internal Revenue Code, overseeing benefit formulas rooted in amendments to the Social Security Act of 1935, and evaluating program integrity measures coordinated with entities such as the Government Accountability Office and the Office of Management and Budget. The subcommittee liaises with state authorities such as the California Department of Health Care Services and national organizations including the American Medical Association and the Kaiser Family Foundation on eligibility, reimbursement, and fiscal sustainability matters.

Membership typically includes representatives from districts across states like California, New York, Texas, Florida, and Pennsylvania, and often features lawmakers with prior service on panels such as the House Committee on Ways and Means and the House Committee on the Budget. Leadership posts—chair and ranking member—have been held by members associated with caucuses including the Congressional Black Caucus and the Republican Study Committee, and sometimes by figures who later sought leadership roles in bodies like the House Republican Conference or the House Democratic Caucus. Staff and counsel frequently have backgrounds from institutions such as the Brookings Institution, the Heritage Foundation, and law schools like Harvard Law School and Yale Law School.

The subcommittee has shaped major legislation affecting programs such as Medicare, Medicaid, and the Children's Health Insurance Program. It contributed provisions to landmark measures like the Social Security Amendments of 1965 that created Medicare, the Balanced Budget Act of 1997, and the Medicare Prescription Drug, Improvement, and Modernization Act that established Part D. More recent legislative engagements have involved deliberations over repeal and replacement proposals for the Patient Protection and Affordable Care Act, amendments related to the Tax Cuts and Jobs Act of 2017 with implications for health coverage, and bipartisan efforts addressing prescription drug pricing debated alongside stakeholders such as Pfizer, Johnson & Johnson, and advocacy groups like AARP.

The subcommittee conducts oversight hearings featuring testimony from administrators of the Centers for Medicare & Medicaid Services, executives from insurers including UnitedHealth Group and Anthem, Inc., patient advocates from organizations such as the March of Dimes, and academic experts from universities like Johns Hopkins University and Columbia University. Hearings have addressed subjects ranging from program integrity and fraud investigations pursued with the Department of Justice to emergency responses involving the Centers for Disease Control and Prevention during public health crises like the COVID-19 pandemic. Investigations and reports often cite audits by the Government Accountability Office and analyses from federal budget entities including the Congressional Budget Office.

Decisions and oversight by the subcommittee have influenced presidential initiatives from administrations such as those of Richard Nixon, Bill Clinton, and Donald Trump, and have affected stakeholder strategies in the pharmaceutical sector represented by firms like Merck & Co. and AbbVie. The subcommittee’s role in shaping entitlement financing, eligibility rules, and provider payment systems has had ripple effects on state policymaking in jurisdictions like New York (state), Texas, and Massachusetts, and on legal challenges adjudicated in the United States Court of Appeals for the D.C. Circuit and the Supreme Court of the United States. Its legislative choices continue to intersect with fiscal policy deliberations in the United States Congress and advocacy campaigns by organizations such as Families USA and the American Hospital Association.